Osteoarthritis Trial, Recruiting NCT07496203 Sponsor: Hacettepe University Condition: Osteoarthritis
Back to Osteoarthritis

Osteoarthritis Trial, Recruiting

NCT07496203
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been diagnosed with knee osteoarthritis using a standard set of medical diagnostic guidelines known as the ACR criteria
  • People whose knee osteoarthritis has been classified as stage 2 or 3 on a standard X-ray grading system called the Kellgren-Lawrence scale
  • People who have had an injection directly into the knee joint within the past month
  • People who are 18 years of age or older
  • People who are able to read and write
  • People who have read and signed a form giving their informed consent to take part

Who may not be able to join:

  • People who have a history of a major psychiatric illness
  • People who have or have had a cancer or malignant disease
  • People who have a long-term infectious disease or another rheumatological (joint-related) disease
  • People who have experienced a serious knee injury or had knee surgery in the last 6 months
  • People who have a disease affecting the body's connective tissue (such as tendons, ligaments, or cartilage) (confirm with trial site)
  • People who have a history of disease affecting the blood vessels in the limbs, or nerve damage affecting the outer parts of the body
  • People whose knee osteoarthritis has been classified as stage 4 on the Kellgren-Lawrence X-ray grading scale
  • People who have undergone a physiotherapy program for the affected knee within the last 3 months

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Edibe Ünal, Hacettepe University

Phone: +903123052525

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
2 January 2026
Est. completion
20 March 2026

Where this trial is recruiting

Turkey (Türkiye)

Primary endpoints

BETY-BQ; Muscle Strength

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov